{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:41:00Z","timestamp":1778661660445,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Fondo para la Investigaci\u00f3n Sanitaria","award":["PI15\/00513"],"award-info":[{"award-number":["PI15\/00513"]}]},{"name":"Fondo para la Investigaci\u00f3n Sanitaria","award":["RD16\/0015\/0001"],"award-info":[{"award-number":["RD16\/0015\/0001"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministerio de Econom\u00eda y Competitividad. Spain"},{"name":"FEDER"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jns.2019.01.007","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T18:42:34Z","timestamp":1546972954000},"page":"4-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Factors associated with dimethyl fumarate-induced lymphopenia"],"prefix":"10.1016","volume":"398","author":[{"given":"Susana","family":"Sainz de la Maza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelia","family":"Villarrubia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucienne","family":"Costa-Frossard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enric","family":"Monreal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7061-8725","authenticated-orcid":false,"given":"Amalia","family":"Tejeda-Velarde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eulalia","family":"Rodr\u00edguez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 C.","family":"\u00c1lvarez-Cerme\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa M.","family":"Villar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2019.01.007_bb0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1742-2094-9-163","article-title":"Effects of dimethyl fumarate on neuroprotection and immunomodulation","volume":"9","author":"Albrecht","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2019.01.007_bb0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jns.2019.01.007_bb0015","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2019.01.007_bb0020","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","article-title":"Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis","volume":"367","author":"Fox","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2019.01.007_bb0025","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1212\/NXI.0000000000000274","article-title":"Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarate","volume":"3","author":"Baharnoori","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2019.01.007_bb0030","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJMc1415408","article-title":"PML in a patient with lymphocytopenia treated with dimethyl fumarate","volume":"372","author":"Rosenkranz","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2019.01.007_bb0035","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMc1413724","article-title":"PML in a patient without severe lymphocytopenia receiving dimethyl fumarate","volume":"372","author":"Nieuwkamp","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2019.01.007_bb0040","article-title":"Dimethyl fumarate-associated lymphopenia: risk factors and clinical significance","volume":"1","author":"Longbrake","year":"2015","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.jns.2019.01.007_bb0045","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1177\/1352458514559299","article-title":"Dimethyl fumarate associated lymphopenia in clinical practice","volume":"21","author":"Longbrake","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.01.007_bb0050","series-title":"Common Terminology Criteria for Adverse Events v4.0, NCI, NIH, HHS","first-page":"#09","author":"National Cancer Institute","year":"2009"},{"key":"10.1016\/j.jns.2019.01.007_bb0055","article-title":"Optimal response to dimethyl fumarate associates in MS with a shift from an inflammatory to a tolerogenic blood cell profile","author":"Medina","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.01.007_bb0060","article-title":"Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis","volume":"3","author":"Gross","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2019.01.007_bb0065","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/1352458515608961","article-title":"Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients","volume":"22","author":"Longbrake","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.01.007_bb0070","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1212\/NXI.0000000000000211","article-title":"Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets","volume":"3","author":"Lundy","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2019.01.007_bb0075","article-title":"Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS","author":"Fleischer","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.01.007_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40120-016-0042-8","article-title":"Sustained effect of delayed-release dimethyl fumarate in newly diagnosed patients with relapsing-remitting multiple sclerosis: 6-year interim results from an extension of the DEFINE and CONFIRM studies","volume":"5","author":"Gold","year":"2016","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.jns.2019.01.007_bb0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/1352458516649037","article-title":"Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: interim analysis of ENDORSE, a randomized extension study","volume":"23","author":"Gold","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.01.007_bb0090","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1212\/NXI.0000000000000340","article-title":"Dimethyl fumarate\u2013induced lymphopenia in MS due to differential T-cell subset apoptosis","volume":"4","author":"Ghadiri","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2019.01.007_bb0095","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1212\/NXI.0000000000000076","article-title":"Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate","volume":"2","author":"Spencer","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2019.01.007_bb0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.msard.2015.05.003","article-title":"The effect of dimethyl fumarate (Tecfidera) on lymphocyte counts: a potential contributor to progressive multifocal leukoencephalopathy risk","volume":"4","author":"Khatri","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jns.2019.01.007_bb0105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.msard.2015.06.002","article-title":"Effects of dimethyl fumarate on lymphocyte subsets","volume":"4","author":"Berkovich","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jns.2019.01.007_bb0110","article-title":"Lymphocyte subtypes in relapsing\u2013remitting multiple sclerosis patients treated with dimethyl fumarate","volume":"3","author":"Chaves","year":"2017","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.jns.2019.01.007_bb0115","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1084\/jem.20011786","article-title":"Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining","volume":"195","author":"Gumperz","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jns.2019.01.007_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/08830180601070179","article-title":"The in vivo response of invariant natural killer T cells to glycolipid antigens","volume":"26","author":"Parekh","year":"2007","journal-title":"Int. Rev. Immunol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19300073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19300073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:45:49Z","timestamp":1758383149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X19300073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":24,"alternative-id":["S0022510X19300073"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.01.007","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with dimethyl fumarate-induced lymphopenia","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}